WaveStrength
 
serviceshead
Market Report
Archives nav6 Subscribe
Material Profits
Login nav6 Subscribe
Trader
Login nav10 Subscribe
Apex
Login nav18 Subscribe
Wavestrength Options Weekly
Login to Wavestrength Options Weekly Subscribe to Wavestrength Options Weekly
Share Your Opinion
Tune into the first financial news network!
HACKER SAFE certified sites prevent over 99.9% of hacker crime.
spacer
A proud member of theTaipan Group

 

 

Wednesday Oct 11, 2006

RADAR for October 11, 2006

The Dumbest Move Ever

By The WaveStrength Team


Macro Outlook
Comedy: “I think there is more or less consensus for (cutting) 1 million (barrels per day). The reference point is the (official) 28 million bpd ceiling.” - OPEC President Edmund Daukoru (via Reuters)

Why comedy? Because they never really do it. Someone always breaks rank and no one wants to be left out of the fun, so in the end they all just keep pumping as much as they can. Heck, even that official ceiling is a joke: the actual figure is closer to 30 million barrels per day.

Tragedy: Oil speculators will still use this “threat” to bid up crude futures, and we will pay for these games at the pump - and the stock exchange.

More tonight…

Material Profits
Want to hear the dumbest move ever?

Gazprom's gone and kicked everyone out of the running to help develop its gigantic Shtokman gas field.

And to top that off, plans to liquefy most of the natural gas and ship it to the U.S. have been scrapped, though “some” LNG prospects remain on the table. No one's saying how much.

Two U.S. companies and three other companies in the running bidding to become partners in owning the field are now demoted to bidding for only the production and transportation of the resource.

I'll have more later in the week. Stay tuned to TFN for more details.

Trading Tactics
Adam's been saying it for over 6 months now, and it finally looks like it's coming to pass. To put it clearly, Q3 earnings are pushing stocks lower across the board. For example, Alcoa (AA:NYSE) comes out and reports disappointing earnings: And the stock drops. Monsanto (MON:NYSE) comes out and reports disappointing earnings: And the stock drops. Genentech (DNA:NYSE) comes out and reports stellar earnings (beating Wall Street estimates by a full $0.08). And guess what? The stock drops.

If this is any indication of how Wall Street will react to Q3 earnings, then we're in for a very brutal month of selling pressure. I don't know about you, but I'm ready for more puts.

=============================================================

Copyright 2006 by The Taipan Group,LLC. All rights are reserved. Printed in USA. Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies - let the buyer beware! WaveStrength Market Report does not provide individual investment advice, or act as an investment advisor, or individually advocate the purchase or sale of any security or investment.

Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company.

WaveStrength Market Report reserves the right to use email endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber's initials will be used unless express written permission has been granted to the contrary.

The Taipan Group, LLC.expressly forbids its writers from having a financial interest in any security that they recommend to their readers. Furthermore, all employees and agents of The Taipan Group, LLC and its affiliate companies must wait 24 hours before following an initial recommendation published on the Internet, or 72 hours after a printed publication is mailed.

horline

 

Free ELetters
WaveStrength Market Report - Free eletter

We value your privacy!


Dynamic Market Report

Invite a Friend

 © 2004 - 2006 by Taipan Group LLC. 808 Saint Paul St. Baltimore MD 21202